EUROEYES (1846.HK)
- Previous Close
3.000 - Open
2.930 - Bid 3.000 x --
- Ask 3.040 x --
- Day's Range
2.920 - 3.050 - 52 Week Range
2.710 - 5.390 - Volume
224,000 - Avg. Volume
188,197 - Market Cap (intraday)
962.118M - Beta (5Y Monthly) 0.77
- PE Ratio (TTM)
12.00 - EPS (TTM)
0.250 - Earnings Date Mar 31, 2025
- Forward Dividend & Yield 0.06 (2.15%)
- Ex-Dividend Date Jun 10, 2025
- 1y Target Est
5.80
EuroEyes International Eye Clinic Limited provides vision correction services in Germany, the People's Republic of China, Denmark, and the United Kingdom. The company offers laser eye surgery in various options, including SMILE Pro, Femto-Lasik, PRK, and Lasek; refractive laser surgery, such as ReLEx SMILE, Femto LASIK, and Presbyond; lens exchange surgery comprising monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services. It also sells pharmaceutical products; rental of ophthalmic equipment and operating spaces; and provides training service. In addition, the company is involved in the operation of consultation centers and/or clinics for eye treatment, as well as LASIK centers; and trading of eye clinic equipment and lenses. EuroEyes International Eye Clinic Limited was founded in 1993 and is headquartered in Hamburg, Germany.
euroeyes.com322
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 1846.HK
View MorePerformance Overview: 1846.HK
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1846.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1846.HK
View MoreValuation Measures
Market Cap
962.12M
Enterprise Value
628.17M
Trailing P/E
12.04
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.38
Price/Book (mrq)
0.88
Enterprise Value/Revenue
0.88
Enterprise Value/EBITDA
2.53
Financial Highlights
Profitability and Income Statement
Profit Margin
11.50%
Return on Assets (ttm)
3.49%
Return on Equity (ttm)
7.36%
Revenue (ttm)
715.68M
Net Income Avi to Common (ttm)
82.28M
Diluted EPS (ttm)
0.250
Balance Sheet and Cash Flow
Total Cash (mrq)
680.67M
Total Debt/Equity (mrq)
28.36%
Levered Free Cash Flow (ttm)
71.74M